Lindbrook Capital’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$6.92K Sell
911
-13
-1% -$109 ﹤0.01% 1813
2024
Q4
$8.89K Buy
924
+13
+1% +$101 ﹤0.01% 1708
2024
Q3
$5.38K Hold
911
﹤0.01% 1980
2024
Q2
$6.31K Sell
911
-6
-0.7% -$42 ﹤0.01% 1882
2024
Q1
$7.06K Buy
917
+6
+0.7% +$48 ﹤0.01% 1744
2023
Q4
$7.99K Hold
911
﹤0.01% 1658
2023
Q3
$6.64K Hold
911
﹤0.01% 1627
2023
Q2
$6.02K Hold
911
﹤0.01% 1709
2023
Q1
$3.11K Hold
911
﹤0.01% 2057
2022
Q4
$2.53K Buy
+911
New +$2.72K ﹤0.01% 2128
2022
Q3
Sell
-64
Closed 2795
2022
Q2
$0 Sell
64
-468
-88% -$1.83K ﹤0.01% 2651
2022
Q1
$3K Buy
+532
New +$2.6K ﹤0.01% 1841

Other funds holding MDXG

Lindbrook Capital's MDXG Position: Q1 2025 in Review

Lindbrook Capital reduced its MiMedx Group (MDXG) stake by 1.4% in Q1 2025, selling an estimated $109 and leaving 911 shares worth $6.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

Lindbrook Capital first reported a position in MDXG in Q1 2022 and has held it in 12 quarters since. The position peaked at $8.89K in Q4 2024. 218 funds tracked by Wall St. Rank hold MDXG as of Q1 2025.

  • Lindbrook Capital held 911 shares of MiMedx Group worth $6.92K as of Q1 2025.
  • Lindbrook Capital sold 13 MiMedx Group shares in Q1 2025, an estimated $109.
  • MiMedx Group made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1813 holding.
  • Lindbrook Capital first reported a position in MiMedx Group in Q1 2022 and has held it in 12 quarters since.
  • Lindbrook Capital's MiMedx Group position peaked at $8.89K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.